TABLE 1.
MetS |
|||
Variables | Yes (n = 770) | No (n = 1382) | P |
Age | 61 ± 102 | 57 ± 12 | <0.001 |
Sex, % female | 39.4 | 19.6 | <0.001 |
Individual admixture proportion, % | |||
European | 57.4 | 58.0 | 0.14 |
American Indian | 38.6 | 38.2 | 0.21 |
West African | 3.96 | 3.84 | 0.45 |
Urban residence, % | 38.7 | 40.2 | 0.51 |
Income, US $/mo | 567 ± 423 | 570 ± 428 | 0.92 |
Waist:hip ratio | 0.97 ± 0.08 | 0.94 ± 0.07 | <0.001 |
Current smoker, % | 15.1 | 25.1 | <0.001 |
EE on daily activity, MET/d | 33.4 ± 13.1 | 36.7 ± 17.4 | <0.001 |
Dietary variables | |||
Total energy intake, Mcal/d | 2.37 ± 0.772 | 2.50 ± 0.763 | <0.001 |
Total fat, % energy | 32.0 ± 5.41 | 31.8 ± 6.10 | 0.29 |
Saturated fat, % energy | 10.4 ± 2.61 | 10.4 ± 2.73 | 0.68 |
Monounsaturated fat, % energy | 11.8 ± 3.51 | 11.9 ± 4.11 | 0.45 |
Polyunsaturated fat, % energy | 6.38 ± 2.08 | 6.10 ± 1.98 | 0.002 |
Trans fat, % energy | 1.35 ± 0.65 | 1.30 ± 0.64 | 0.10 |
Carbohydrate, % energy | 55.2 ± 6.96 | 55.5 ± 7.54 | 0.38 |
Protein, % energy | 13.3 ± 2.20 | 12.8 ± 2.07 | <0.001 |
Cholesterol, g/d | 0.29 ± 0.17 | 0.30 ± 0.17 | 0.20 |
Fatty acids in adipose tissue: g/100 g total fatty acid | |||
Stearic acid, 18:0 | 2.45 ± 0.85 | 2.92 ± 1.02 | <0.001 |
Oleic acid, 18:1(n-9) | 42.3 ± 2.96 | 42.1 ± 3.18 | 0.14 |
Palmitic acid, 16:0 | 21.0 ± 2.75 | 21.5 ± 2.74 | <0.001 |
Palmitoleic acid, 16:1(n-7) | 7.18 ± 2.28 | 6.30 ± 2.11 | <0.001 |
ALA, 18:3(n-3) | 0.62 ± 0.20 | 0.67 ± 0.21 | <0.001 |
EPA, 20:5(n-3) | 0.042 ± 0.022 | 0.038 ± 0.021 | <0.001 |
DHA, 22:6(n-3) | 0.152 ± 0.053 | 0.139 ± 0.052 | <0.001 |
Linoleic acid, 18:2(n-6) | 15.3 ± 3.70 | 15.7 ± 3.87 | 0.05 |
Arachidonic acid, 20:4(n-6) | 0.52 ± 0.13 | 0.44 ± 0.14 | <0.001 |
Components of MetS, % | |||
Abdominal obesity | 53 | 5 | <0.001 |
Hypertriglyceridemia | 91 | 58 | <0.001 |
Low HDL cholesterol | 86 | 51 | <0.001 |
High BP | 80 | 23 | <0.001 |
High fasting glucose | 36 | 5 | <0.001 |
Values are mean ± SD. Using the definition from the National Cholesterol Education Program's Adult treatment Panel III report. ALA, α-linolenic acid; BP, blood pressure; EE, energy expenditure; MetS, metabolic syndrome; MET, metabolic equivalent.